PRESS RELEASE
News
-
-
PRESS RELEASE
PALFINGER AG: Outstanding results for PALFINGER AG in the first quarter
PALFINGER AG reported outstanding results in Q1 2024 with EUR 578.5 million revenue, record EBIT of EUR 54.7 million and consolidated net result of EUR 32.5 million despite economic challenges. Positive developments in North America, Asia, and the Marine Sector -
-
PRESS RELEASE
Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed
Curatis Holding AG announces completion of business combination with Curatis AG, trading on SIX Swiss Exchange under CURN.SW. Specializes in orphan drugs with risk-balanced model -
-
PRESS RELEASE
BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
BB Biotech reports solid first-quarter results as interest rates impact biotech stock market. Net profit reaches CHF 260 mn. Key portfolio adjustments and milestones highlighted -
PRESS RELEASE
Branicks Group expands business model to include renewables asset class and cooperates with Encavis Asset Management AG
Branicks Group AG expands business model to include renewables asset class through cooperation with Encavis Asset Management AG, focusing on sustainable investments and ESG criteria -
-
REGULATED PRESS RELEASE
Safran - Un rythme de croissance soutenu : prévision annuelle confirmée
Safran publie un chiffre d'affaires en forte croissance au 1er trimestre 2024, confirmant ses perspectives annuelles. Toutes les activités enregistrent une hausse significative, notamment dans la Propulsion et les Équipements & Défense -
